Multivalent heteromultimer scaffold design and constructs
US-10155803-B2 · Dec 18, 2018 · US
Transferrins, e.g. lactoferrins, ovotransferrins
Transferrins, e.g. lactoferrins, ovotransferrins · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/79 |
| Official title | Transferrins, e.g. lactoferrins, ovotransferrins |
| Display label | Transferrins, e.g. lactoferrins, ovotransferrins |
| Total patents | 225 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 16 |
| 2016 | 22 |
| 2017 | 15 |
| 2018 | 18 |
| 2019 | 26 |
| 2020 | 25 |
| 2021 | 21 |
| 2022 | 16 |
| 2023 | 23 |
| 2024 | 18 |
| 2025 | 18 |
| 2026 | 7 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Human-derived ferritin monomer fragment and fusion polypeptide using same
US-2018291072-A1 · Oct 11, 2018 · US
Anti-transferrin receptor antibodies with tailored affinity
US-2018282408-A1 · Oct 4, 2018 · US
Compositions and Methods for the Diagnosis of Retinal Neovascularization
US-2018251839-A1 · Sep 6, 2018 · US
Transferrin receptor transgenic models
US-2018235195-A1 · Aug 23, 2018 · US
Methods and compositions for enhanced biomass production and increased abiotic stress tolerance
US-2018168120-A1 · Jun 21, 2018 · US
Polypeptides Targeting HIV Fusion
US-2018111980-A1 · Apr 26, 2018 · US
Fibronectin based scaffold domain proteins that bind to myostatin
US-2017354718-A1 · Dec 14, 2017 · US
Lactoferrin-conjugated nanoparticle complex and use thereof
US-2017281797-A1 · Oct 5, 2017 · US
Human lactoferrin derived peptide for use as an antigen masking agent
US-9724422-B2 · Aug 8, 2017 · US
Modified polynucleotides for the production of intrabodies
US-2017210788-A1 · Jul 27, 2017 · US
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
US-2017190761-A1 · Jul 6, 2017 · US
Multivalent heteromultimer scaffold design and constructs
US-2017174745-A1 · Jun 22, 2017 · US
Method of purifying/concentrating sugar chains with a sugar chain-trapping molecule and method of analyzing sugar chain structure
US-9683006-B2 · Jun 20, 2017 · US
Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin
US-9661868-B2 · May 30, 2017 · US
Fibronectin based scaffold domain proteins that bind to myostatin
US-9662373-B2 · May 30, 2017 · US
Fusion protein having factor VII activity
US-9644197-B2 · May 9, 2017 · US
Fusion protein having factor IX activity
US-9617328-B2 · Apr 11, 2017 · US
Enzymatic omega-oxidation and omega-amination of fatty acids
US-9611489-B2 · Apr 4, 2017 · US
Fibronectin based scaffold domain proteins that bind to myostatin
US-2017088602-A1 · Mar 30, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/79?
- CPC C07K14/79 is the Cooperative Patent Classification code for “Transferrins, e.g. lactoferrins, ovotransferrins.”
- How many patents are filed under CPC C07K14/79 (Transferrins, e.g. lactoferrins, ovotransferrins)?
- Our database includes 225 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/79 growing?
- Publication counts under this code: 18 in 2024 vs 18 in 2025 (latest complete years).